Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    18375998 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI
Condition: Myocardial Infarction
Interventions: Other: abciximab followed by implantation of bare metal stent;   Other: abciximab and Sirolimus eluting stent;   Other: tirofiban and bare metal stent;   Other: tirofiban and sirolimus-eluting stent
2 Suspended Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina;   Percutaneous Coronary Intervention
Interventions: Drug: Tirofiban (Aggrastat);   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.